Actinium Pharmaceuticals Inc (ATNM)
1.535
-0.08
(-4.66%)
USD |
NYAM |
Apr 01, 09:58
Actinium Pharmaceuticals Max Drawdown (5Y): 95.56% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Bristol-Myers Squibb Co | 47.67% |
| Merck & Co Inc | 36.65% |
| Eli Lilly and Co | 24.27% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 98.13% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.89 |
| Beta (5Y) | -0.2735 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.26% |
| Historical Sharpe Ratio (5Y) | -0.2831 |
| Historical Sortino (5Y) | -0.5456 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.49% |